🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Spain / NCT06996418
Active, not recruiting Not applicable

Intergenerational Mealtime at a Shared Site: A Small-scale Trial

NCT06996418 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-02-18
Last updated
2025-05-31

Condition(s) studied

Healthy NutritionIntergenerational RelationsWell-beingRelational CareEatingMealtimes

Investigational drug(s) / intervention(s)

Intergenerational mealtime (intervention + follow-up)Intergenerational mealtime (wait + intervention)

Intergenerational mealtime (intervention + follow-up): Intergenerational lunchtime at an intentional intergenerational dining room 4 days a week for 8 weeks. Once this period is over, this group will move on to a follow-up phase that will last for another 8 weeks, during which they will eat 5 days a week in different dining rooms with their generational peers, as they had been doing up to the time of the intervention. Finally, they will undergo a last follow-up period of about 2 weeks.

Intergenerational mealtime (wait + intervention): Waiting period consisting of 8 weeks (while Intervention Group #1 is using the intergenerational dining room). During this period toddlers and older people will eat lunch 5 days a week with their generational peers in separate dining rooms as they have been doing before the intervention. They will then move to eating together lunch 4 days a week for 8 weeks in the intergenerational dining room. Once this period is over they will enter a final follow-up phase for about 2 weeks during which they will go back to eat in generationally separate dining rooms.

Study summary

The goal of this study is to find out whether having children and older people who attend an intergenerational center eating lunch together on a regular basis may be an improvement over continuing to eat lunch with their generational peers in separate dining rooms at the center.

Specifically, the study analyzes the functioning and potential impact of an intergenerational dining room in terms of healthy eating, nutrition, self-evaluation of health and well-being, relational care, nutritional knowledge, and intergenerational attitudes. For this purpose, it sets up, in an intergenerational center, a dining room attended by children aged 2-3 years and older people aged 75 years and older who had previously been taking their lunch in separate dining rooms at the center.

The main questions this study aims to answer are:

* Does eating lunch at the intergenerational dining room improve the intake of healthy foods by children and older people compared to eating at their usual separate dining rooms with their peers?
* Does this type of intergenerational dining room serve as a space for nutritional education of children and older people?
* Does the experience of eating together have a positive influence in terms of children's attitudes towards older people and vice versa?

Eligibility

Sex
ALL
Min age
2 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria (older people): * Informed consent signed by each participant or his/her legal representative. * Eating autonomy: Ability to feed oneself without continuous assistance from another person. * Expected stay at the Intergenerational Center until July 2025. * Negative certificate of Sexual Offenses (mandatory in case of contact with minors). * Screening for nutritional risk, dysphagia and oral health: Exclusion of persons with severe untreated malnutrition, severe dysphagia or oral problems preventing chewing. * Adequate cognitive status: mild or moderate cognitive impairment (rating ≤5 on the Global Deterioration Scale - GDS). Inclusion Criteria (toddlers): * Informed consent: Signature of the legal guardian authorizing participation in the study. * Child's assent: Positive expression of willingness to participate. * Feeding autonomy: Ability to eat without continuous assistance from an adult. * Expected permanence in the Intergenerational Center until July 2025. Exclusion Criteria (older adults): * Advanced cognitive impairment (GDS \> 5) affecting comprehension and social interaction. * Severe dysphagia or oral health problems preventing normal feeding. * Unstable medical conditions that limit intergenerational dining attendance. * History of aggressive behavior or history of refusal to interact with children. * Lack of consent or refusal to participate in any of the study assessments. Exclusion Criteria (toddlers): * Need for ongoing feeding assistance. * Severe medical conditions affecting feeding or social participation (e.g. severe metabolic disease). * Expectation of transfer or departure from the Intergenerational Center prior to completion of the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centro Intergeneracional de Referencia de Macrosad Albolote Granada

More Universidad de Granada trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06996418 on ClinicalTrials.gov ↗ ← All trials in Spain